• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases.原发性头颈部血管肉瘤的特征与预后:一项基于监测、流行病学和最终结果计划(SEER)的1250例病例分析
Head Neck Pathol. 2019 Sep;13(3):378-385. doi: 10.1007/s12105-018-0978-3. Epub 2018 Oct 24.
2
Head & neck acinar cell carcinoma: a population-based study using the seer registry.头颈部腺泡细胞癌:基于 SEER 注册中心的一项人群研究。
BMC Cancer. 2020 Jul 8;20(1):631. doi: 10.1186/s12885-020-07066-y.
3
Malignant peripheral nerve sheath tumors of the head and neck: Demographics, clinicopathologic features, management, and treatment outcomes.头颈部恶性外周神经鞘瘤:人口统计学、临床病理特征、管理及治疗结果
Oral Oncol. 2015 Dec;51(12):1088-94. doi: 10.1016/j.oraloncology.2015.08.012. Epub 2015 Oct 9.
4
Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study.颌骨骨肉瘤的特征和预后因素:一项回顾性队列研究。
JAMA Otolaryngol Head Neck Surg. 2015 May 1;141(5):470-7. doi: 10.1001/jamaoto.2015.0340.
5
Survival predictors of metastatic angiosarcomas: a surveillance, epidemiology, and end results program population-based retrospective study.转移性血管肉瘤的生存预测因素:监测、流行病学和最终结果计划基于人群的回顾性研究。
BMC Cancer. 2020 Aug 18;20(1):778. doi: 10.1186/s12885-020-07300-7.
6
Factors Associated With Survival in Patients With Synovial Cell Sarcoma of the Head and Neck: An Analysis of 167 Cases Using the SEER (Surveillance, Epidemiology, and End Results) Database.头颈部滑膜肉瘤患者生存相关因素:利用监测、流行病学和最终结果(SEER)数据库对167例病例的分析
JAMA Otolaryngol Head Neck Surg. 2016 Jun 1;142(6):576-83. doi: 10.1001/jamaoto.2016.0384.
7
Prognostic Factors and Survival Outcome in Patients with Chordoma in the United States: A Population-Based Analysis.美国脊索瘤患者的预后因素和生存结果:一项基于人群的分析。
World Neurosurg. 2017 Aug;104:346-355. doi: 10.1016/j.wneu.2017.04.118. Epub 2017 Apr 27.
8
Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.脊柱骨肉瘤和尤因肉瘤的预后决定因素及治疗结果分析
Spine J. 2017 May;17(5):645-655. doi: 10.1016/j.spinee.2016.11.002. Epub 2016 Nov 14.
9
The demographic features, clinicopathologic characteristics, treatment outcome and disease-specific prognostic factors of solitary fibrous tumor: a population-based analysis.孤立性纤维瘤的人口统计学特征、临床病理特征、治疗结果及疾病特异性预后因素:一项基于人群的分析。
Oncotarget. 2015 Dec 8;6(39):41875-83. doi: 10.18632/oncotarget.6174.
10
Ewing Sarcoma of the Head and Neck.头颈部尤因肉瘤
Ann Otol Rhinol Laryngol. 2017 Mar;126(3):179-184. doi: 10.1177/0003489416681322. Epub 2017 Jan 5.

引用本文的文献

1
Angiosarcoma: a systematic review of biomarkers in diagnosis, prognosis, and therapeutic strategies.血管肉瘤:关于诊断、预后及治疗策略中生物标志物的系统综述
Front Oncol. 2025 Jul 1;15:1623327. doi: 10.3389/fonc.2025.1623327. eCollection 2025.
2
A Clinicopathologic Feature and Survival Analysis of Cutaneous Angiosarcoma: A Single Tertiary Center Study.皮肤血管肉瘤的临床病理特征及生存分析:一项单中心三级医院研究
Ann Dermatol. 2025 Apr;37(2):68-74. doi: 10.5021/ad.24.086.
3
Personalized Treatment for Scalp Angiosarcoma.头皮血管肉瘤的个性化治疗
J Clin Med. 2025 Feb 14;14(4):1278. doi: 10.3390/jcm14041278.
4
A 37-Year Retrospective Analysis Reveals a High Rate of Cutaneous Angiosarcoma of the Scalp in Okinawa, Japan.一项37年的回顾性分析显示,日本冲绳头皮皮肤血管肉瘤的发病率很高。
Cancer Sci. 2025 Apr;116(4):1059-1067. doi: 10.1111/cas.16453. Epub 2025 Jan 16.
5
Angiosarcoma: clinical outcomes and prognostic factors, a single-center analysis.血管肉瘤:临床结果和预后因素,单中心分析。
J Cancer Res Clin Oncol. 2024 Jun 25;150(6):326. doi: 10.1007/s00432-024-05835-x.
6
A Population-Based Long-Term Follow-Up of Soft Tissue Angiosarcomas: Characteristics, Treatment Outcomes, and Prognostic Factors.基于人群的软组织血管肉瘤长期随访:特征、治疗结果及预后因素
Cancers (Basel). 2024 May 11;16(10):1834. doi: 10.3390/cancers16101834.
7
Case Report: A rare case of multicentric angiosarcomas of bone mimicking multiple myeloma on F-FDG PET/CT.病例报告:1例罕见的骨多中心血管肉瘤在F-FDG PET/CT上酷似多发性骨髓瘤。
Front Med (Lausanne). 2023 Nov 28;10:1330341. doi: 10.3389/fmed.2023.1330341. eCollection 2023.
8
Outcomes after definitive treatment for cutaneous angiosarcomas of the face and scalp: Reevaluating the role of surgery and radiation therapy.头面部皮肤血管肉瘤的确定性治疗后结局:重新评估手术和放疗的作用。
Head Neck. 2023 Aug;45(8):1943-1951. doi: 10.1002/hed.27418. Epub 2023 Jun 5.
9
Primary angiosarcoma of the ascending colon diagnosed after the discovery of intraoral tumor.升结肠原发性血管肉瘤在口腔内肿瘤被发现后确诊。
Clin J Gastroenterol. 2023 Apr;16(2):193-197. doi: 10.1007/s12328-022-01745-y. Epub 2022 Dec 20.
10
Cutaneous Angiosarcoma of the Head and Neck-A Retrospective Analysis of 47 Patients.头颈部皮肤血管肉瘤——47例患者的回顾性分析
Cancers (Basel). 2022 Aug 8;14(15):3841. doi: 10.3390/cancers14153841.

本文引用的文献

1
Cutaneous Angiosarcoma: The Possibility of New Treatment Options Especially for Patients with Large Primary Tumor.皮肤血管肉瘤:新治疗方案的可能性,尤其适用于原发性大肿瘤患者。
Front Oncol. 2018 Mar 2;8:46. doi: 10.3389/fonc.2018.00046. eCollection 2018.
2
Cutaneous angiosarcoma: update on biology and latest treatment.皮肤血管肉瘤:生物学更新及最新治疗。
Curr Opin Oncol. 2018 Mar;30(2):107-112. doi: 10.1097/CCO.0000000000000427.
3
Clinicopathological features and prognostic factors in angiosarcoma: A retrospective analysis of 200 patients from a single Chinese medical institute.血管肉瘤的临床病理特征及预后因素:来自中国一家医疗机构的200例患者的回顾性分析
Oncol Lett. 2017 Nov;14(5):5370-5378. doi: 10.3892/ol.2017.6892. Epub 2017 Sep 6.
4
Survival outcomes for cutaneous angiosarcoma of the scalp versus face.头皮与面部皮肤血管肉瘤的生存结果。
Head Neck. 2017 Jun;39(6):1205-1211. doi: 10.1002/hed.24747. Epub 2017 Apr 11.
5
Predisposing factors for poor prognosis of angiosarcoma of the scalp and face: Systematic review and meta-analysis.头皮和面部血管肉瘤预后不良的危险因素:系统评价与Meta分析
Head Neck. 2017 Feb;39(2):380-386. doi: 10.1002/hed.24554. Epub 2016 Aug 10.
6
A prognostic model for resectable soft tissue and cutaneous angiosarcoma.可切除性软组织和皮肤血管肉瘤的预后模型。
J Surg Oncol. 2016 Oct;114(5):557-563. doi: 10.1002/jso.24352. Epub 2016 Jul 4.
7
Angiosarcoma of the Head and Neck.头颈部血管肉瘤
Int Arch Otorhinolaryngol. 2015 Jul;19(3):191-5. doi: 10.1055/s-0035-1547520. Epub 2015 Mar 10.
8
Angiosarcoma of the scalp and face: the Mayo Clinic experience.头皮和面部血管肉瘤:梅奥诊所的经验
JAMA Otolaryngol Head Neck Surg. 2015 Apr;141(4):335-40. doi: 10.1001/jamaoto.2014.3584.
9
Prognostic features in angiosarcoma of the head and neck: a retrospective monocenter study.头颈部血管肉瘤的预后特征:一项回顾性单中心研究
J Craniomaxillofac Surg. 2014 Dec;42(8):1623-8. doi: 10.1016/j.jcms.2014.05.002. Epub 2014 May 15.
10
Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: a multicentre, retrospective study.紫杉烷类药物的放化疗在皮肤血管肉瘤的治疗中优于传统手术和放疗:一项多中心回顾性研究。
Br J Dermatol. 2014 Dec;171(6):1493-500. doi: 10.1111/bjd.13110. Epub 2014 Nov 10.

原发性头颈部血管肉瘤的特征与预后:一项基于监测、流行病学和最终结果计划(SEER)的1250例病例分析

Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases.

作者信息

Lee Kevin C, Chuang Sung-Kiang, Philipone Elizabeth M, Peters Scott M

机构信息

Division of Oral and Maxillofacial Surgery, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY, USA.

Department of Oral and Maxillofacial Surgery, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Head Neck Pathol. 2019 Sep;13(3):378-385. doi: 10.1007/s12105-018-0978-3. Epub 2018 Oct 24.

DOI:10.1007/s12105-018-0978-3
PMID:30357539
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6684669/
Abstract

Head and neck angiosarcomas (HN-AS) are rare malignancies with a poor prognosis relative to other soft tissue sarcomas. To date, the HN-AS literature has been limited to short reports and single-institution experiences. This study evaluated patients registered with the Surveillance, Epidemiology, and End Results (SEER) program who had been diagnosed with a primary HN-AS. Predictors were drawn from demographic and baseline tumor characteristics. Outcomes were survival months and cause of death. Kaplan-Meier analyses were used to estimate overall (OS) and disease-specific survival (DSS) rates. Cox proportional hazards regression models were used for multivariate analyses. A total of 1250 patients (mean age 73.3 years) were identified, and nearly all lesions (93.5%) were cutaneous. Two- and 5-year OS rates were 47.3% (95% CI 44.3-50.3) and 26.5% (95% CI 23.7-29.3), while 2- and 5-year DSS rates were 66.6% (95% CI 63.6-69.6) and 48.3% (95% CI 44.5-52.1). In the univariate analyses, age, race, tumor grade, tumor size, AJCC stage, SEER historic stage, and surgery were significant predictors of both OS and DSS. Multivariate regression revealed that independent predictors of poor OS and DSS were older age [OS: HR 1.04 (95% CI 1.02-1.05), p < 0.01; DSS: HR 1.03 (95% CI 1.01-1.05), p < 0.01], increased tumor size [OS: HR 1.01 (95% CI 1.01-1.01), p < 0.01; DSS: HR 1.01 (95% CI 1.01-1.02), p < 0.01], and distant disease [OS: HR 2.97 (95% CI 1.65-5.34), p < 0.01; DSS: HR 4.99 (95% CI 2.50-9.98), p < 0.01]. Age, tumor size, and disease extent were determinants of HN-AS survival. When all other factors were controlled, lower histologic grade and surgery did not improve the risk of death.

摘要

头颈部血管肉瘤(HN-AS)是一种罕见的恶性肿瘤,与其他软组织肉瘤相比预后较差。迄今为止,关于HN-AS的文献仅限于简短报告和单机构经验。本研究评估了监测、流行病学和最终结果(SEER)计划登记的诊断为原发性HN-AS的患者。预测因素来自人口统计学和基线肿瘤特征。结局指标为生存月数和死亡原因。采用Kaplan-Meier分析估计总生存率(OS)和疾病特异性生存率(DSS)。采用Cox比例风险回归模型进行多变量分析。共确定了1250例患者(平均年龄73.3岁),几乎所有病变(93.5%)为皮肤病变。2年和5年OS率分别为47.3%(95%CI 44.3-50.3)和26.5%(95%CI 23.7-29.3),而2年和5年DSS率分别为66.6%(95%CI 63.6-69.6)和48.3%(95%CI 44.5-52.1)。在单变量分析中,年龄、种族、肿瘤分级、肿瘤大小、美国癌症联合委员会(AJCC)分期、SEER历史分期和手术是OS和DSS的重要预测因素。多变量回归显示,OS和DSS较差的独立预测因素为年龄较大[OS:风险比(HR)1.04(95%CI 1.02-1.05),p<0.01;DSS:HR 1.03(95%CI 1.01-1.05),p<0.01]、肿瘤大小增加[OS:HR 1.01(95%CI 1.01-1.01),p<0.01;DSS:HR 1.01(95%CI 1.01-1.02),p<0.01]和远处转移[OS:HR 2.97(95%CI 1.65-5.34),p<0.01;DSS:HR 4.99(95%CI 2.50-9.98),p<0.01]。年龄、肿瘤大小和疾病范围是HN-AS生存的决定因素。当控制所有其他因素时,较低的组织学分级和手术并不能降低死亡风险。